Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)
Ivan Gentile(University of Naples Federico II), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Guglielmo Borgia(University of Naples Federico II), Giulio Viceconte(University of Naples Federico II), Antonio Riccardo Buonomo(University of Naples Federico II), Laura Staiano, Margherita Macera(University of Campania "Luigi Vanvitelli"), Riccardo Scotto(University of Naples Federico II), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Teresa De Simone, Grazia Tosone(University of Naples Federico II), Carmine Coppola, Federica Portunato(Ospedale Policlinico San Martino), Daniela Caterina Amoruso, Stefania De Pascalis(University of Campania "Luigi Vanvitelli")
Cited by 63
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
|PLoS ONE|2020|128
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
|Clinical Microbiology and Infection|2020|104